EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diabetes Mellitus in Patients With Autoimmune Hepatitis: Frequency, Risk Factors and Effect on Outcome

Sarah Flatley iD, Selena Dixon, Eleanor Pilsworth, Asha Dube, Barbara Hoeroldt, Laura Harrison iD, Dermot Gleeson iD

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.70188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Sarah Flatley und 6 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, Prednisolone, Diabetes Mellitus, Glucocorticoids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment for autoimmune hepatitis (AIH) includes corticosteroids, which are associated with the development of diabetes mellitus (DM). Reported new‐onset DM rates in patients with AIH have varied, and predisposing factors and prognostic implications are inadequately characterised.

Aim

To identify the frequency and predisposing factors for DM in AIH and its association with disease progression and mortality.

Methods

Retrospective/prospective single‐centre study of 494 patients with AIH presenting 1987–2023, 466 receiving corticosteroids (454 prednisolone, 12 budesonide) and followed for (median (range) 9 (0–36) years).

Results

Forty‐seven patients (10%) already had DM at AIH diagnosis. New‐onset DM subsequently developed in another 59 (13%). In those receiving prednisolone, new‐onset DM incidence was 8% ± 1% after 1 year and 14% ± 2% after 10 years (14‐ and 3‐fold higher than expected population rate), and was independently associated with older age, non‐Caucasian ethnicity, higher initial prednisolone dose, higher BMI at diagnosis and more weight gain after 2 years of follow‐up. New‐onset DM usually persisted despite stopping prednisolone. New‐onset DM and DM at any time were independently associated with all‐cause death/transplantation rate, along with previously established risk factors (older age, cirrhosis, lower ALT at diagnosis and failure of early ALT normalisation). New‐onset DM and DM at any time were also independently associated with cirrhosis development. Similar associations of new‐onset DM and DM at any time with liver‐related death/transplantation were significant on univariate but not multivariate analysis.

Conclusion

New‐onset DM occurred in 13% of patients with AIH, was related to older age, non‐Caucasian ethnicity, higher prednisolone dose, higher BMI at diagnosis and weight gain; and was an independent predictor of all‐cause death/transplantation and of cirrhosis development, underlining the need to minimise steroid burden in AIH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis, AutoimmunePrednisoloneDiabetes MellitusGlucocorticoidsAdrenal Cortex HormonesHumansMaleFemaleRisk FactorsAdultMiddle AgedRetrospective StudiesProspective StudiesAgedAdolescentYoung AdultChildTreatment OutcomeDisease Progression

Stichwörter der Autor:innen

autoimmune hepatitiscirrhosisdiabetes mellitusliveroutcomeprevalencerisk factors

Substanzen

PrednisoloneGlucocorticoidsAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Liver Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, University of Sheffield Medical School, Sheffield, UK.
  • Department of Histopathology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

ORCID-Profile: Sarah Flatley, Laura Harrison, Dermot Gleeson

Zitieren

APA

Flatley, S., Dixon, S., Pilsworth, E., Dube, A., Hoeroldt, B., Harrison, L., & Gleeson, D. (2025). Diabetes Mellitus in Patients With Autoimmune Hepatitis: Frequency, Risk Factors and Effect on Outcome. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70188

Vancouver

Flatley S, Dixon S, Pilsworth E, Dube A, Hoeroldt B, Harrison L, et al. Diabetes Mellitus in Patients With Autoimmune Hepatitis: Frequency, Risk Factors and Effect on Outcome. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70188

BibTeX
@article{Flatley2025,
  author = {Flatley, Sarah and Dixon, Selena and Pilsworth, Eleanor and Dube, Asha and Hoeroldt, Barbara and Harrison, Laura and Gleeson, Dermot},
  title = {Diabetes Mellitus in Patients With Autoimmune Hepatitis: Frequency, Risk Factors and Effect on Outcome},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.70188}
}
Kostenlos starten →